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The effect of retinotd on human leukemia K562 cell differentiation induced by hemm was exammed. Retinoids (retmoic acid and synthetic retinotds 
[Am80 and ChSS]) dose-dependently enhanced hemin-induced erythroid differentiation of K562 cells, though these retmoids themselves dtd not 
induce the differentiation Under optimal conditions. these retmoids caused a doubhng of the populatton of hemin-induced ifferentiated cells. In 
addition, co-treatment of cells with hemin and retmoid led to longer maintenance of the differenttated state after the removal of hemin, which mtght 
imply aquisition of irreversibility of hemin-induced ifferentiation. These results suggest hat the combination of retinoids with other differenttatron 
inducers might be useful for leukemia therapy in cases where the leukemic cells are poorly responsive or unresponsive to retmolds. alone. 
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1. INTRODUCTION 
Retinoids. namely natural and synthetic bioisosteres 
of retinoic acid (RA), have been shown to exhibit a 
variety of effects on the growth and differentiation of 
both normal and tumor cells [l]. Biological activities 
elicited by retinoids are believed to be based on the 
activation of their nuclear receptors, retinoic acid recep- 
tors (RARcl. $3 and -y), which regulate specific gene 
expression, From a clinical standpoint, the differentia- 
tion-inducing activity of retinoids on acute promyeloid 
leukemia (APL) cells from both patients and cell lines 
is of particular interest [Z], and has been applied to the 
treatment of APL 13-51. However, in spite of the wide- 
ranging biological activities of retinoids, their clinical 
utilization is restricted at present to APL therapy. 
The K562 ceil line was established by Lozzio and 
Lozzio from a patient with chronic myeloid leukemia 
(CML) in terminal blast crisis [6] and this cell line can 
be induced to undergo erythroid differentiation by var- 
ious compounds, including hemin [7]. However, it is not 
responsive to retinoids, though the cells do contain 
RARs [S]. 
To explore the therapeutic potential of retinoids in 
some types of leukemia other than APL, in this study, 
we have investigated the effects of retinoids on hemin- 
K562 cells (4 x lO~/ml) were incubated with hemin m the presence 
or absence of a retinord for 4 days. The erythroid differentiation of 
the cells was scored by benzidine staming according to the procedure 
reported by Cooper et al. [13]. 
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2.4. Merhod of drug removal 
Abbrerrarmns~ Am80, 4-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naph- The incubated cells were pelleted by low-speed centifugation (750 
thalenylcarbamoyl)benzoic acid; ChSS. (E)-4-[3-(3.5-di-tert-butyl- rpm) and washed twice with PBS. The washed cell pellet was resus- 
phenyl)-3-oxo-I-propenyllbenzotc a id; RA. all-trans-retmotc acid; pended m a new medium and reincubated for 4 days. followed by 
APL, acute promyelotd leukemia. benzidme staining. 
induced differentiation of K562 cell line. As retinoids, 
we chose retinoic acid (RA) and two synthetic retinoids 
(4-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyi-2-naphthalen- 
ylcarbamoyl)-benzoic acid. Am80 [9] and (E)-4-[3-(3,5- 
di-terr-butylphenyl)-3-oxo-1-propenyllbenzoic acid, 
Ch55 [lo]; structures shown in Fig. 3). Both Am80 and 
Ch55 are potent retinoids which show higher activity 
than RA in human leukemia HL-60 cell differentiation- 
induction assay [9-121. 
2. MATERIALS AND METHODS 
The K562 cell line used in this work, which was provided by Prof. 
Takashi Tsuruo (Institute of Molecular and Cellular Bioscrences, Uni- 
versity of Tokyo), was maintained m RPM1 1640 supplemented with 
5% fetal bovine serum. The cultures were mcubated at 37°C in a 5% 
CO: humidified incubator. They were subcultured every 2-4 days to 
mamtam them m a state of logarithmic growth. 
Solutions of RA, Am80 and Ch55 were prepared by dissolving each 
drug in absolute ethanol. Hemin was dissolved a mixture of ethanol 
and pyridine (4:1, v/v). Addition of drugs to cell cultures was per- 
formed so as to make the final concentration of organic solvent no 
higher than 0.5% v/v. 
2.3. Assay qf er~throid dj~~renfiufzu~ 
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Frg. 1. Effect of Am80 on K563 cell growth. and differenttatton- 
mducmg ability of Am80. K562 cells (4 x lO’/ml) were mcubated for 
4 days m the presence of the indicated concentratton of Am80. and 
then counted and assayed for erythrotd differenttatton by benztdme 
staining. The total cell number (A) (right). and the percentage of 
benztdine-posttive cells (0) (left) are shown. 
3. RESULTS 
3.1. Effect of Am80 on KS62 cell groltlth and its dgyeren- 
tiability 
The effects of Am80 on K562 cell growth and on the 
inducibility of K562 cell differentiation are shown in 
Fig. 1. Am80 itself did not inhibit K563 cell growth at 
concentrations of up to 1 ,uM. This result is consistent 
with the very low toxicity of the compound [9,11,12]. 
Further, Am80 possessed no differentiation-inducing 
activity on K562 cells at concentrations up to 10 PM. 
RA and Ch55 also failed to induce K562 cell differenti- 
ation (data not shown). Therefore. it can be concluded 
that the retinoids had no effect on K562 cell growth/ 
differentiation in the concentration ranges examined. 
3.2. Efect of Am80 on K562 cell differentiation indw 
tion 64’ hemin 
Though Am80 itself had no ability to induce erthy- 
roid differentiation of K562 cells, it dramatically aug- 
mented the population of hemin-induced benzidine-pos- 
itive K562 cells (Fig. 2). The benzidine-positive cells 
induced from K562 cells by co-treatment with hemin 
and Am80 were microscopically indistinguishable from 
those induced by treatment with hemin alone. This en- 
hancement of hemin-induced K562 cell differentiation 
by Am80 could be observed at Am80 concentrations as 
low as 10 nM and was dose-dependent up to 1 PM. The 
maximum augmentation was observed at 1 ,uM Am80 
and 2.5 ,uM hemin, and amounted to approximately 
200%. It was observed that when the hemin concentra- 
tion was comparatively low. Am80 augmented K562 
cell differentiation more efficiently. 
3.3. Effect of retinoids other than Am80 
We also evaluated the ability of RA and Ch55 to 
augment hemin-induced K562 cell differentiation (Fig. 
3). As we had expected, RA and Ch55 augmented 
hemin-induced differentiation of K562 cells as effec- 
tively as Am80. The concentration giving approxi- 
mately 100% augmentation of the hemin-induced differ- 
entiation was 1 ,uM for RA and Am80. and 100 nM for 
Ch55. This order of potency is in good coincidence with 
that of their activity to induce HL-60 cell differentiation 
and that of their binding affinity toward RAR~xI-/? [99 
121. 
3.4. Effect of retinoid on maintenance of the d$fferenti- 
ated state of K562 cells 
The induction of K562 cell differentiation by hemin 
is reversible [14]. so it was of interest to investigate the 
effect of Am80 on the kinetics of hemin-induced differ- 
entiation. K562 cells were exposed to 10 PM hemin in 
the presence or absence of 1 ,uM Am80 for 4 days. The 
cells were then washed, resuspended in fresh medium 
with or without Am80, and assayed for benzidine-posi- 
tive cells after reincubation for 4 days. After the re- 
moval of hemin, the majority of the cells differentiated 
by hemin alone reverted to the undifferentiated state, as 
reported [14]. On the other hand, approximately 50% of 
those differentiated by hemin in the presence of Am80 
retained their differentiated state, whether Am80 was 
contained in the reincubation medium or not (Fig. 4). 
Consequently. co-treatment of cells with hemin and 
Am80 resulted in longer maintenance of the differenti- 
ated state after the removal of hemin. 
80 
1 
20 
, ’ 0 10 -8 I 1o-7 ’ 10 -6 
Am80 (M) 
Fig. 2. Effect of Am80 on hemin-Induced K562 cell differentiatton. 
K562 cells (4 x lO’/ml) were incubated for 4 days in the presence of 
7.5 ,uM (0) or 5 PM (A) hemm with the indicated concentratton of 
Am80, followed by assay of benztdine stammg. The percentage of 
benridine-posittve cells IS shown. 
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4. DISCUSSION 
In this work, we examined the effect of retinoids on 
hemin-induced ifferentiation of the K.562 cell line. We 
found that retinoids augmented the differentiation of 
K562 cells induced by hemin, though the retinoids 
themselves are neither differentiation-inducing nor 
toxic toward K562 cells. In other words, hemin con- 
ferred upon K562 cells a retinoid-responsiveness a re- 
gards erythroid differentiation. This ability to augment 
hemin-induced ifferentiation of K.562 cells seems to be 
a general property of retinoids because RA and Ch55 
showed similar effects to Am80. Considering the exis- 
tence of RARc( and -p in K562 cells [S] and the estab- 
lished selectivity of these retinoids for retinoid-binding 
proteins [11,12], i.e. (1) Am80 and Ch55 are RAR-spe- 
cific (no binding to retinoid x receptors (RXRs)), (2) 
Ch55 does not bind CRABP, and (3) Am80 is RARE/- 
p-selective (no binding to RARy), the effects of these 
retinoids are presumably elicited by the activation of 
RARa and/or RARP. The order of potency of these 
retinoids to augment he hemill-induced K.562 cell dif- 
ferentiation is the same as that of their affinity for 
RARaI-P. 
RA 1pM Am80 1f1M ChSS 1OOnM Hemtn 2 Svk.4 
+ + + 
Hemin 2 5pM Hemin 2 5vM Hemin 2 SUM 
Fig. 3. Effect of the three retinotds on hemm-Induced K562 differenti- 
ation. KS62 cells (4 x 10J/ml) were incubated for 4 days in the presence 
of 2.5pM hemm m the presence or absence of the indicated concentra- 
tion ofa retmotd. and then assayed by benzidine staining. The percent- 
age of benzldine-positive cells IS shown. Shadowed porttons Indicate 
the percentage (19.4%) of differentiated cells mduced by hemin alone. 
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Fig. 4. Effect of retmotd on the kinetics of hemm-induced KS62 ceil 
differentiation after removal of the drugs. K563 cells (4 x lO“/ml) were 
Incubated for 4 days in the presence of 10 PM hemin with (A) or 
wtthout (B.C) 1 PM Am80. then washed twice in PBS and reincubated 
for 4 days wtth (C) or without (A.B) 1 yM Am80. The cells were then 
assayed by benzidme statning The values are relative values based on 
the number of differentiated cells m 1 mi at the end of the first 4-day 
Incubation at the indicated concentration. taken as I unit. Closed bars 
and open bars indicate the presence of hemin (10 PM) and Am80 t I 
PM), respectively. in the incubation medta. 
In addition, retinoids influenced the kinetics of 
hemin-induced ifferentiation after the removal of the 
drugs, that is, hemin-induced differentiation of K562 
cells seemed to acquire irreversibility in the presence of 
Am80, at least in part. There might exist a retinoid- 
responsive gene(s) which confers irreversibility on 
hemin-induced K562 ceil differentiation. It was re- 
ported that hemin does not affect c-nz~‘c expression in 
K562 cells [ 1.51, though c-~n~c expression is known to be 
suppressed in various cell lines in the course of induc- 
tion of terminal differentiation. For example, RA, 
Am80 and Ch55 strongly suppressed c-m~‘f expression 
in HL-60 cells prior to terminal differentiation [16]. 
Identification of such retinoid responsive-gene(s) (one 
of the candidates being c+nyc) is in progress. 
Our results presented here would suggest that reti- 
noids in combination with other differentiation inducers 
could be useful for leukemia therapy in cases where the 
leukemic cells are not responsive to retinoid, alone. 
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